Osnat Elyashiv

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Replacement Therapy

Hodgkin Lymphoma

Top Venues

OncoTargets and therapy

Current oncology reports

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

This page only lists publications with an associated author ORCID identifier.

Publications

Osnat Elyashiv, Natalie Aleohin, Zohar Migdan, Sophia Leytes, Ofri Peled, Ori Tal, Tally Levy
The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients. Cancers 16 (3) (2024)
Osnat Elyashiv, Natalie Aleohin, Zohar Migdan, Sophia Leytes, Ofri Peled, Ori Tal, Tally Levy
The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients. Cancers 16 (3) (2024)
Rowan E Miller, Osnat Elyashiv, Karim Hussien El-Shakankery, Jonathan A Ledermann
Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors. OncoTargets and therapy 15 (2022)
Osnat Elyashiv, Yien Ning Sophia Wong, Jonathan A Ledermann
Frontline Maintenance Treatment for Ovarian Cancer. Current oncology reports 23 (8) (2021)
Osnat Elyashiv, Jonathan A Ledermann, Gita Parmar, Laura Farrelly, Nicholas Counsell, Amanda Feeney, Fatima El-Khouly, Ian Macdonald, Andreia Neto, Esther Arthur-Darkwa, Eva Burnett, Gordon C Jayson, Linda Mileshkin, Charlie Gourley, Shibani Nicum
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 31 (1) (2020)